Protein detail

ATL4

ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1)

Entry name
ATL4
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
2
Transmembrane count
Protein classification
Disease related genesHuman disease related genesPredicted secreted proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information11
Protein Names
ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1)
Protein Class (3)
Disease related genesHuman disease related genesPredicted secreted proteins
Protein Function (3)
  • Disease related genes
  • Human disease related genes:Congenital malformations:Congenital malformations of eye
  • Predicted secreted proteins
Entrez Gene Symbol
Gene Synonym (2)
DKFZP434K1772TSRC1
Gene Description
ADAMTS like 4
Chromosome
1
Position
150549369-150560937
Supporting publications (n)
2
EVMP confidence score
0.38
Fluorescence & Localization5
Tissue SpecificintestineCell SpecificCytotrophoblastsSingle-Nuclei Brain Specificmammillary bodySecretome LocationSecreted in other tissuesSecretome FunctionReceptor
Function & Pathway6
Relations & Evidence20

Ligand-Receptor Signaling (19)

19 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularGO_IntercellNoNoYesNoNo
intracellularintracellularOmniPathNoNoYesNoNo
ecm_regulatorecm_regulatorMatrisomeYesNoYesNoNo
ecm_regulatorecm_regulatorOmniPathYesNoYesNoNo
secreted_peptidasesecreted_peptidaseOmniPathNoNoYesNoNo
secretedsecretedUniProt_keywordNoNoYesNoNo
secretedsecretedUniProt_locationNoNoYesNoNo
secretedsecretedHPA_secretomeNoNoYesNoNo
secretedsecretedOmniPathNoNoYesNoNo
Page 2 of 2Previous

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry140689422
Sequence, Structure & Domains8

Sequences

Length
1,074
Mass
116,545
Sequence
MENWTGRPWLYLLLLLSLPQLCLDQEVLSGHSLQTPTEEGQGPEGVWGPWVQWASCSQPCGVGVQRRSRTCQLPTVQLHPSLPLPPRPPRHPEALLPRGQGPRPQTSPETLPLYRTQSRGRGGPLRGPASHLGREETQEIRAARRSRLRDPIKPGMFGYGRVPFALPLHRNRRHPRSPPRSELSLISSRGEEAIPSPTPRAEPFSANGSPQTELPPTELSVHTPSPQAEPLSPETAQTEVAPRTRPAPLRHHPRAQASGTEPPSPTHSLGEGGFFRASPQPRRPSSQGWASPQVAGRRPDPFPSVPRGRGQQGQGPWGTGGTPHGPRLEPDPQHPGAWLPLLSNGPHASSLWSLFAPSSPIPRCSGESEQLRACSQAPCPPEQPDPRALQCAAFNSQEFMGQLYQWEPFTEVQGSQRCELNCRPRGFRFYVRHTEKVQDGTLCQPGAPDICVAGRCLSPGCDGILGSGRRPDGCGVCGGDDSTCRLVSGNLTDRGGPLGYQKILWIPAGALRLQIAQLRPSSNYLALRGPGGRSIINGNWAVDPPGSYRAGGTVFRYNRPPREEGKGESLSAEGPTTQPVDVYMIFQEENPGVFYQYVISSPPPILENPTPEPPVPQLQPEILRVEPPLAPAPRPARTPGTLQRQVRIPQMPAPPHPRTPLGSPAAYWKRVGHSACSASCGKGVWRPIFLCISRESGEELDERSCAAGARPPASPEPCHGTPCPPYWEAGEWTSCSRSCGPGTQHRQLQCRQEFGGGGSSVPPERCGHLPRPNITQSCQLRLCGHWEVGSPWSQCSVRCGRGQRSRQVRCVGNNGDEVSEQECASGPPQPPSREACDMGPCTTAWFHSDWSSKCSAECGTGIQRRSVVCLGSGAALGPGQGEAGAGTGQSCPTGSRPPDMRACSLGPCERTWRWYTGPWGECSSECGSGTQRRDIICVSKLGTEFNVTSPSNCSHLPRPPALQPCQGQACQDRWFSTPWSPCSRSCQGGTQTREVQCLSTNQTLSTRCPPQLRPSRKRPCNSQPCSQRPDDQCKDSSPHCPLVVQARLCVYPYYTATCCRSCAHVLERSPQDPS
Alternative Products
Event=Alternative splicing; Named isoforms=3; Name=1; IsoId=Q6UY14-1; Sequence=Displayed; Name=2; IsoId=Q6UY14-2; Sequence=VSP_052183, VSP_052184; Name=3; IsoId=Q6UY14-3; Sequence=VSP_055759
Alternative Sequence
411; E -> EAPLLPLRHAFFLLPGAGSGDSTG (in isoform 3); 854..877; CSAECGTGIQRRSVVCLGSGAALG -> VSPEPPAISCILGNHAQDTSAFPA (in isoform 2); 878..1074; Missing (in isoform 2)

Domain & Motif Annotations

Compositional Bias
103..119; Polar residues; 132..152; Basic and acidic residues; 206..226; Polar residues; 310..323; Gly residues
Domain (FT)
48..93; TSP type-1 1; 723..782; TSP type-1 2; 783..842; TSP type-1 3; 845..909; TSP type-1 4; 910..969; TSP type-1 5; 970..1026; TSP type-1 6; 1029..1066; PLAC
Region
77..342; Disordered
Clinical Relevance1
Antibody
Supporting Publications2
PMIDTitleAbstract
36443833UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.And PTRF in exosomes has been identified as a potential biomarker in multiple malignancies such as glioma and renal cell carcinoma. Functionally, we found that UBE2O inhibited the effects of PTRF on exosome secretion via decreasing caveolae formation. Furthermore, we found that SDPR promotes PTRF expression in exosomes. However, the mechanisms of how to regulate the secretion of exosome-related PTRF remain unknown. Importantly, UBE2O decreased exosome secretion, resulting in downregulating PTRF secretion via exosomes. Interestingly, even in the presence of SDPR, UBE2O still inhibited the secretion of exosome-related PTRF. It is known that Polymerase I and Transcript Release Factor (PTRF, also known as Caveolin-associated Protein-1, CAVIN1) plays an important role in caveolae formation and exosome secretion. Our study demonstrated that UBE2O downregulated exosome release and controlled the secretion of exosome-related PTRF through ubiquitinating PTRF. Since exosomes play an important role in malignant tumor growth and PTRF included in exosomes is a biomarker for several malignant tumors, increasing UBE2O expression in cells has the potential to be developed as a novel approach for cancer treatment. The effect of UBE2O on the secretion of exosome-related PTRF was analyzed by western blot, and the effect of UBE2O on exosome secretion was evaluated by exosome markers and the total protein content of exosomes.
38385960Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer.The combined detection of urinary exosome SDPR and ACBD7 has a certain diagnostic value for bladder cancer.